Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BEAM |
---|---|---|
09:32 ET | 8698 | 26.34 |
09:34 ET | 4025 | 26.115 |
09:36 ET | 755 | 26.01 |
09:38 ET | 400 | 26.13 |
09:39 ET | 2751 | 25.97 |
09:41 ET | 3047 | 25.825 |
09:43 ET | 3929 | 25.69 |
09:45 ET | 1027 | 25.75 |
09:48 ET | 1512 | 25.81 |
09:50 ET | 2578 | 25.85 |
09:52 ET | 3612 | 25.98 |
09:54 ET | 2111 | 26.08 |
09:56 ET | 4964 | 25.93 |
09:57 ET | 406 | 25.9528 |
09:59 ET | 1000 | 25.91 |
10:01 ET | 1624 | 25.9373 |
10:03 ET | 3322 | 26.01 |
10:06 ET | 5013 | 25.99 |
10:08 ET | 1288 | 26.19 |
10:10 ET | 306 | 26.17 |
10:12 ET | 1100 | 26.16 |
10:14 ET | 832 | 26.12 |
10:15 ET | 5686 | 26.09 |
10:17 ET | 819 | 26.16 |
10:19 ET | 763 | 26.17 |
10:21 ET | 1600 | 26.06 |
10:24 ET | 1400 | 25.96 |
10:26 ET | 900 | 25.75 |
10:28 ET | 2343 | 25.715 |
10:30 ET | 4768 | 25.655 |
10:32 ET | 1168 | 25.605 |
10:33 ET | 888 | 25.62 |
10:35 ET | 5711 | 25.495 |
10:37 ET | 2200 | 25.66 |
10:39 ET | 2489 | 25.64 |
10:42 ET | 1586 | 25.69 |
10:44 ET | 200 | 25.64 |
10:46 ET | 2260 | 25.805 |
10:48 ET | 400 | 25.87 |
10:50 ET | 1700 | 25.72 |
10:51 ET | 3062 | 25.79 |
10:53 ET | 2800 | 25.835 |
10:55 ET | 1545 | 25.83 |
10:57 ET | 2000 | 25.84 |
11:00 ET | 580 | 25.865 |
11:02 ET | 4626 | 25.805 |
11:04 ET | 2542 | 25.775 |
11:06 ET | 900 | 25.775 |
11:08 ET | 2333 | 25.83 |
11:09 ET | 2250 | 25.89 |
11:11 ET | 1423 | 25.95 |
11:13 ET | 2921 | 26.02 |
11:15 ET | 300 | 26.01 |
11:18 ET | 600 | 25.99 |
11:20 ET | 1640 | 26.005 |
11:22 ET | 1400 | 25.87 |
11:24 ET | 2200 | 25.89 |
11:26 ET | 2238 | 25.93 |
11:27 ET | 1600 | 25.84 |
11:29 ET | 2000 | 25.81 |
11:31 ET | 500 | 25.74 |
11:33 ET | 1726 | 25.82 |
11:36 ET | 1000 | 25.85 |
11:38 ET | 600 | 25.825 |
11:40 ET | 600 | 25.86 |
11:42 ET | 500 | 25.85 |
11:44 ET | 700 | 25.88 |
11:45 ET | 600 | 25.93 |
11:47 ET | 1200 | 25.97 |
11:49 ET | 1200 | 26 |
11:51 ET | 2900 | 25.98 |
11:54 ET | 500 | 25.99 |
11:56 ET | 3920 | 26.01 |
11:58 ET | 1600 | 25.955 |
12:00 ET | 202 | 25.94 |
12:02 ET | 600 | 25.9729 |
12:03 ET | 500 | 25.96 |
12:05 ET | 700 | 25.94 |
12:07 ET | 200 | 25.92 |
12:09 ET | 500 | 25.97 |
12:12 ET | 1209 | 25.92 |
12:14 ET | 2232 | 25.835 |
12:18 ET | 100 | 25.81 |
12:20 ET | 1887 | 25.8 |
12:23 ET | 866 | 25.84 |
12:25 ET | 500 | 25.93 |
12:27 ET | 2839 | 25.98 |
12:30 ET | 100 | 26 |
12:32 ET | 959 | 25.97 |
12:34 ET | 532 | 25.93 |
12:36 ET | 100 | 25.9 |
12:38 ET | 100 | 25.93 |
12:39 ET | 1330 | 26 |
12:41 ET | 100 | 25.97 |
12:43 ET | 600 | 25.97 |
12:48 ET | 556 | 26 |
12:50 ET | 1200 | 25.9 |
12:54 ET | 1309 | 25.94 |
12:56 ET | 1169 | 25.93 |
12:57 ET | 1817 | 25.94 |
12:59 ET | 300 | 25.96 |
01:01 ET | 461 | 25.9 |
01:08 ET | 300 | 25.88 |
01:10 ET | 2247 | 25.84 |
01:14 ET | 1927 | 25.855 |
01:15 ET | 900 | 25.78 |
01:17 ET | 200 | 25.78 |
01:19 ET | 2866 | 25.75 |
01:21 ET | 1557 | 25.83 |
01:24 ET | 761 | 25.84 |
01:26 ET | 825 | 25.845 |
01:28 ET | 400 | 25.87 |
01:32 ET | 100 | 25.88 |
01:33 ET | 300 | 25.89 |
01:35 ET | 500 | 25.88 |
01:37 ET | 300 | 25.94 |
01:39 ET | 300 | 25.95 |
01:42 ET | 1303 | 25.97 |
01:44 ET | 1223 | 26.01 |
01:48 ET | 300 | 25.92 |
01:50 ET | 100 | 25.93 |
01:53 ET | 1500 | 25.97 |
01:55 ET | 300 | 25.94 |
02:00 ET | 1100 | 25.95 |
02:02 ET | 1000 | 25.92 |
02:04 ET | 500 | 25.95 |
02:06 ET | 200 | 25.89 |
02:08 ET | 1247 | 25.875 |
02:09 ET | 200 | 25.91 |
02:11 ET | 1779 | 25.95 |
02:13 ET | 300 | 25.95 |
02:15 ET | 100 | 25.935 |
02:18 ET | 272 | 25.911 |
02:20 ET | 200 | 25.88 |
02:22 ET | 100 | 25.86 |
02:24 ET | 1719 | 25.9 |
02:26 ET | 890 | 25.86 |
02:27 ET | 2568 | 25.9 |
02:29 ET | 4486 | 26 |
02:31 ET | 800 | 25.99 |
02:33 ET | 1053 | 25.97 |
02:36 ET | 701 | 25.99 |
02:38 ET | 4106 | 26 |
02:40 ET | 500 | 25.95 |
02:42 ET | 1776 | 25.97 |
02:44 ET | 2227 | 25.95 |
02:45 ET | 200 | 25.94 |
02:47 ET | 496 | 25.9 |
02:49 ET | 300 | 25.93 |
02:51 ET | 709 | 25.94 |
02:54 ET | 1100 | 25.92 |
02:56 ET | 276 | 25.871 |
02:58 ET | 700 | 25.92 |
03:00 ET | 1217 | 25.93 |
03:02 ET | 1700 | 26 |
03:03 ET | 1100 | 25.9 |
03:05 ET | 600 | 25.8 |
03:09 ET | 600 | 25.86 |
03:12 ET | 200 | 25.87 |
03:14 ET | 500 | 25.82 |
03:16 ET | 973 | 25.78 |
03:18 ET | 2764 | 25.785 |
03:20 ET | 1709 | 25.86 |
03:21 ET | 705 | 25.82 |
03:23 ET | 100 | 25.83 |
03:27 ET | 300 | 25.85 |
03:30 ET | 200 | 25.83 |
03:32 ET | 1500 | 25.87 |
03:34 ET | 2100 | 25.91 |
03:36 ET | 9575 | 25.94 |
03:38 ET | 2200 | 25.93 |
03:39 ET | 1976 | 25.94 |
03:41 ET | 1461 | 25.9 |
03:43 ET | 2907 | 25.805 |
03:45 ET | 1591 | 25.76 |
03:48 ET | 15311 | 25.86 |
03:50 ET | 2282 | 25.845 |
03:52 ET | 821 | 25.74 |
03:54 ET | 2561 | 25.705 |
03:56 ET | 4290 | 25.66 |
03:57 ET | 2524 | 25.65 |
03:59 ET | 120900 | 25.62 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Beam Therapeutics Inc | 2.2B | -14.5x | --- |
Galapagos NV | 2.0B | 57.9x | --- |
Catalyst Pharmaceuticals Inc | 2.4B | 38.3x | --- |
Veracyte Inc | 2.5B | -45.2x | --- |
Genmab A/S | 17.7B | 21.3x | +22.71% |
Maravai LifeSciences Holdings Inc | 2.1B | -9.2x | --- |
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
---|---|
Revenue (TTM) | $352.6M |
Shares Outstanding | 82.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.85 |
EPS | $-1.76 |
Book Value | $12.02 |
P/E Ratio | -14.5x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.